Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
2.530
-0.010 (-0.39%)
At close: Dec 5, 2025, 4:00 PM EST
2.500
-0.030 (-1.19%)
After-hours: Dec 5, 2025, 7:55 PM EST
Xenetic Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 4.12 | 6.17 | 8.98 | 13.1 | 18.24 | 11.53 | Upgrade
|
| Cash & Short-Term Investments | 4.12 | 6.17 | 8.98 | 13.1 | 18.24 | 11.53 | Upgrade
|
| Cash Growth | -39.74% | -31.36% | -31.41% | -28.21% | 58.27% | 11.19% | Upgrade
|
| Prepaid Expenses | 0.65 | 0.39 | 0.1 | 0.56 | 0.25 | 0.84 | Upgrade
|
| Other Current Assets | 0.3 | 0.03 | 0.5 | - | 0.23 | - | Upgrade
|
| Total Current Assets | 5.07 | 6.59 | 9.59 | 13.65 | 18.72 | 12.37 | Upgrade
|
| Property, Plant & Equipment | - | - | - | - | - | 0.03 | Upgrade
|
| Other Long-Term Assets | - | 0.31 | 1.02 | 0.67 | 0.69 | 0.68 | Upgrade
|
| Total Assets | 5.07 | 6.9 | 10.61 | 14.72 | 19.82 | 13.18 | Upgrade
|
| Accounts Payable | 0.51 | 0.28 | 0.24 | 0.29 | 0.36 | 0.33 | Upgrade
|
| Accrued Expenses | 0.46 | 0.61 | 0.57 | 0.79 | 1.03 | 0.57 | Upgrade
|
| Current Portion of Leases | - | - | - | - | 0.03 | 0.04 | Upgrade
|
| Other Current Liabilities | 0.14 | - | - | - | - | - | Upgrade
|
| Total Current Liabilities | 1.11 | 0.89 | 0.81 | 1.07 | 1.42 | 0.94 | Upgrade
|
| Long-Term Leases | - | - | - | - | - | 0.03 | Upgrade
|
| Total Liabilities | 1.11 | 0.89 | 0.81 | 1.07 | 1.42 | 0.96 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 208.28 | 208.23 | 208.05 | 207.77 | 205.95 | 194.13 | Upgrade
|
| Retained Earnings | -199.3 | -197.19 | -193.23 | -189.1 | -182.55 | -176.9 | Upgrade
|
| Treasury Stock | -5.28 | -5.28 | -5.28 | -5.28 | -5.28 | -5.28 | Upgrade
|
| Comprehensive Income & Other | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | Upgrade
|
| Total Common Equity | 3.95 | 6.01 | 9.79 | 13.64 | 18.39 | 12.21 | Upgrade
|
| Shareholders' Equity | 3.96 | 6.01 | 9.8 | 13.65 | 18.39 | 12.22 | Upgrade
|
| Total Liabilities & Equity | 5.07 | 6.9 | 10.61 | 14.72 | 19.82 | 13.18 | Upgrade
|
| Total Debt | - | - | - | - | 0.03 | 0.06 | Upgrade
|
| Net Cash (Debt) | 4.12 | 6.17 | 8.98 | 13.1 | 18.22 | 11.47 | Upgrade
|
| Net Cash Growth | -39.74% | -31.36% | -31.41% | -28.10% | 58.89% | 10.58% | Upgrade
|
| Net Cash Per Share | 2.67 | 4.00 | 5.88 | 9.21 | 17.72 | 17.94 | Upgrade
|
| Filing Date Shares Outstanding | 2.29 | 1.54 | 1.54 | 1.52 | 1.34 | 0.87 | Upgrade
|
| Total Common Shares Outstanding | 1.54 | 1.54 | 1.54 | 1.52 | 1.34 | 0.87 | Upgrade
|
| Working Capital | 3.96 | 5.69 | 8.78 | 12.58 | 17.3 | 11.43 | Upgrade
|
| Book Value Per Share | 2.56 | 3.89 | 6.36 | 9.00 | 13.68 | 13.97 | Upgrade
|
| Tangible Book Value | 3.95 | 6.01 | 9.79 | 13.64 | 18.39 | 12.21 | Upgrade
|
| Tangible Book Value Per Share | 2.56 | 3.89 | 6.36 | 9.00 | 13.68 | 13.97 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.